Dr. Melissa R. Griffith, M.D.
Rheumatology (Rheumatology Physician)
12605 E 16th Ave
Aurora, CO 80045
Who else practices at this address →
Adams County includes primary care (2% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Medical College of Georgia School of Medicine (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 147
Licensed in Colorado since 2016, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: Medical College of Georgia School of Medicine
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
CO license DR.0057161 (first issued 2016; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Colorado Hospital Authority Aurora, CO
- Uch-Memorial Health System Colorado Springs, CO
- Poudre Valley Hospital Fort Collins, CO
- Uchealth Highlands Ranch Hospital Highlands Ranch, CO
- Uchealth Broomfield Hospital Broomfield, CO
Medical groups
- University Physicians Incorporated (3,215 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 147
- Services billed
- 410
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 125 | 102 |
| Established patient office or other outpatient visit, 20-29 minutes | 20 | 19 |
| Established patient office or other outpatient visit, 40-54 minutes | 19 | 19 |
| New patient office or other outpatient visit, 60-74 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in Aurora, CO | 74 |
| Methotrexate (methotrexate sodium) Other prescribers in Aurora, CO | 47 |
| Mycophenolate Mofetil Other prescribers in Aurora, CO | 38 |
| Actemra Actpen (tocilizumab) | 34 |
| Hydroxychloroquine Sulfate Other prescribers in Aurora, CO | 29 |
| Leucovorin Calcium | 17 |
| Humira(Cf) Pen (adalimumab) Other prescribers in Aurora, CO | 14 |
| Benlysta (belimumab) | 13 |
| Leflunomide Other prescribers in Aurora, CO | 11 |
| Kineret (anakinra) | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 4 payments worth $268 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $169 |
|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.05 |
| Amgen Inc. | $24.80 |
| E.r. Squibb & Sons, L.l.c. | $21.01 |
| Travel and Lodging | $169 |
|---|---|
| Food and Beverage | $98.86 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Apr 4, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Chicago, IL Company’s descriptionResearch Related Service | $169 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 3 companies. The companies reported $661,179 in research payments for these studies, mostly to the institutions running them.
- A Phase 1, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted Nex-T Chimeric Antigen Receptor (CAR) T Cells, in Participants with Severe, Refractory Autoimmune Diseases: Systemic Lupus Erythematosus…
Celgene Corporation - A Phase 2, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted NEXT CAR T Cells, in Participants with Active SLE (Including Lupus Nephritis) with Inadequate Response to Glucocorticoids and at Least 2…
Celgene Corporation - A Phase 1, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted Nex-T Chimeric Antigen Receptor (CAR) T Cells, in Participants with Severe, Refractory Autoimmune Diseases: Systemic Lupus Erythematosus…
E.r. Squibb & Sons, L.l.c. - A Multicenter,Randomized,Double blind,Placebo controlled,Phase III Study to Evaluate the Efficacy and Safety of Anifrolumab in Adult Patients with Systemic Sclerosis
AstraZeneca Pharmaceuticals LP - A Phase 2, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted NEXT CAR T Cells, in Participants with Active SLE (Including Lupus Nephritis) with Inadequate Response to Glucocorticoids and at Least 2…
E.r. Squibb & Sons, L.l.c. - A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
E.r. Squibb & Sons, L.l.c. · Active, not recruiting · NCT07015983
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.